SARS-CoV-2-IN-106
SARS-CoV-2-IN-106 (compound 19) is a SARS-CoV-2 papain-like protease inhibitor with the IC50 values of 0.44 μM and 0.18 μM for PLpro enzymatic and viral replication , respectively[1].
Product Specifications
CAS Number
2863607-73-0
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-106.html
Smiles
C[C@@H](N1CCC(CC1)C(NCC2=CC(NC(N3CCN(CC3)C)=O)=CC(F)=C2)=O)C4=CC=CC5=C4C=CC=C5
Molecular Formula
C31H38FN5O2
Molecular Weight
531.66
References & Citations
[1]Shan H, et al. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Cell Chem Biol. 2021;28 (6) :855-865.e9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041907-100 1x 100 µL
STAT3 / Signal Transducer and Activator of Transcription 3 (PCRP-STAT3-2F12), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 